Inoue Makoto, Akimoto Tetsu, Saito Osamu, Ando Yasuhiro, Muto Shigeaki, Kusano Eiji
Department of Internal Medicine, Division of Nephrology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Clin Exp Nephrol. 2008 Aug;12(4):296-299. doi: 10.1007/s10157-008-0039-4. Epub 2008 Feb 15.
We report a case of nephrotic syndrome and acute renal failure that developed in a 73-year-old woman after six months of treatment with the non-steroidal anti-inflammatory drug (NSAID) diclofenac. Renal biopsy revealed interstitial nephritis and minimal change nephropathy. Despite discontinuation of treatment with diclofenac, she subsequently became anuric and required hemodialysis for progressive azotemia. Since her anuria was persistent, treatment with prednisone at a dose of 30 mg/day was started. With progressive increase in urine output after the initiation of corticosteroid treatment, a constant decrease in serum creatinine was observed along with improvement of creatinine clearance. In addition, the increased urinary excretion of beta2-microglobulin (beta2MG) and N-acetyl-beta-D-glucosaminidase (NAG) on admission was also improved during the treatment. Our findings suggest that corticosteroid treatment should be reserved for patients with the protracted deterioration of renal function even after discontinuation of offending trigger agents.
我们报告一例73岁女性在使用非甾体抗炎药双氯芬酸治疗六个月后出现肾病综合征和急性肾衰竭的病例。肾活检显示间质性肾炎和微小病变性肾病。尽管停用了双氯芬酸治疗,但她随后无尿,并因进行性氮质血症需要血液透析。由于她持续无尿,开始使用剂量为30mg/天的泼尼松治疗。在开始使用皮质类固醇治疗后,随着尿量逐渐增加,观察到血清肌酐持续下降,同时肌酐清除率有所改善。此外,入院时增加的β2-微球蛋白(β2MG)和N-乙酰-β-D-氨基葡萄糖苷酶(NAG)尿排泄量在治疗期间也有所改善。我们的研究结果表明,即使在停用致病触发因素后肾功能仍持续恶化的患者,也应采用皮质类固醇治疗。